Archives of Pharmacology and Therapeutics
Department of Medical Biology
University Medical Center Utrecht
Dr. Bahram A. Badlou is Head of Research and Development group, BBAdvies and Research, Zeist, The Netherlands. He graduated with PhD degree in University Medical Center Utrecht, The Netherlands. Dr. Badlou is Chairman of Biobanking, London, UK. He worked as reviewer and guest editor of different international biomedical journals. Dr. Badlou is Chairman of European Biology congress for Iranian students 2007, Hamburg, Germany and Chairman of first International Platelets Meeting 2011 in Tehran, Iran. He rotated through several laboratories in association with interdisciplinary graduate program learning techniques. He has more than 15 years of Clinical and Basic Research Medical Scientific training and experiences to develop novel model systems to prevent human patho-physiological processes at microscopic and macroscopic levels, using Chemistry and Biochemistry approaches in Health and during diseases. His major achievements are: 1. Unravel how shelf life of human cells and organs can be prolonged using Biochemistry and metabolic approaches; 2. Which model system are working for aging related diseases; 3. How apoptotic processes and mitochondrial damages could be delayed; 4. How The Regeneration Medicine in the subjects works; 5. How different antibodies can be validated 6. How we can be localized stem cells for the Regeneration Medicine. Dr. Badlou’s research interests include Ageing-Related Diseases, Regeneration Medicine, Transfusion and Transplantation Sciences, Platelets in Health and Diseases, And PRP Technologies.
Ageing-Related Diseases, Regeneration Medicine, Transfusion and Transplantation Sciences, Platelets in Health and Diseases, And PRP Technologies
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.